David Enloe's Email & Phone Number

💼 Past Experience

David Enloe is currently a Head of Viral-based Therapeutics at Lonza from August 2010 to December 2013 (3 years 5 months). Our biologics contract manufacturing start-up, Vivante GMP Solutions, was purchased by Lonza, a comprehensive, multi-national leader in the area of biopharma contract services and manufacturing. The business we built at Vivante is now Lonza's viral manufacturing business unit. Founder, President and CEO at Vivante GMP Solutions, Inc. from June 2009 to August 2010 (1 year 3 months). Vivante is the biologics contract manufacturing company that was purchased out of Introgen Therapeutics' Chapter 11 proceedings on June 1, 2009. Our entire team that was at Introgen and subsequently Introgen Technical Services (ITS) is transitioning to Vivante. We look forward to serving the viral GMP and process development marketplace for the next many years. CEO at Introgen Technical Services from January 2008 to June 2009 (1 year 6 months). Sales and Services Manager, Rocky Mountains at Baker Hughes Centrilift from June 1991 to June 1992 (1 year 1 month). Finance and Operations Manager, Rocky Mountains at Baker Hughes Centrilift from November 1989 to June 1991 (1 year 8 months). Auditor at Arthur Andersen & Co. from 1986 to 1989 (3 years). Corporate Executive Officer at Ajinomoto. General Manager, SE Asia at Baker Hughes Centrilift from June 1992 to March 1995 (2 years 10 months) in Jakarta, Indonesia. President and CEO at Althea, CMO in Greater San Diego Area. President and CEO at Introgen Therapeutics, Inc. from December 2008 to June 2009 (7 months). President and CEO at Ajinomoto Bio-Pharma Services in Tokyo, Japan. COO at Introgen Therapeutics, Inc. from March 1995 to November 2008 (13 years 9 months).

🎓 Education

David Enloe's work readiness based on his education is:David Enloe is a highly accomplished business professional with over 20 years of experience in the accounting field. His skills and experience make him a excellent choice for any accounting position. He has a strong interest in accounting and has a special interest in working with financial systems.

💡 Technical & Interpersonal Skills

Pradeep Jewett, Senior Director, Corporate Development, AjinomotoDavid Enloe is a Head of Viral-based Therapeutics at Lonza and he has been with the company since August 2010. He is responsible for leading the company's viral manufacturing business unit and has a background in business development and project management. Before coming to Lonza, David was a Vice President at Althea and subsequently CMO at Introgen Therapeutics. He was also President and CEO at Ajinomoto Bio-Pharma Services for 13 years.David has a keen interest in viruses and their biology. He is currently responsible for the development of Vivante's viral manufacturing business unit and has experience in both project management and business development. He is a fluent English speaker and has done a great job of coaching and mentoring his team members.